Thus, the decreased IL‐2 levels, potentially driven by changes in PRKG1, seen in individuals with diabetes and COVID‐19 may impair this immune mechanism, predisposing individuals with diabetes to worsened immune responses. The gene discussed is PRKG1; the disease is COVID-19.